Correlation Between Cardio Diagnostics and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Capricor Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Capricor Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Capricor Therapeutics
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cardio and Capricor is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Capricor Therapeutics
Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to generate 2.25 times more return on investment than Capricor Therapeutics. However, Cardio Diagnostics is 2.25 times more volatile than Capricor Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 2.91 in Cardio Diagnostics Holdings on September 25, 2024 and sell it today you would earn a total of 6.24 from holding Cardio Diagnostics Holdings or generate 214.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.31% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Capricor Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
Capricor Therapeutics |
Cardio Diagnostics and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Capricor Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.Cardio Diagnostics vs. Fate Therapeutics | Cardio Diagnostics vs. Caribou Biosciences | Cardio Diagnostics vs. Karyopharm Therapeutics | Cardio Diagnostics vs. X4 Pharmaceuticals |
Capricor Therapeutics vs. Fate Therapeutics | Capricor Therapeutics vs. Caribou Biosciences | Capricor Therapeutics vs. Karyopharm Therapeutics | Capricor Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |